📰 Executive Albert Bourla News
Page 2 - Executive Albert Bourla News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Executive Albert Bourla. Real-time updates on events, politics, business and more.
February 1, 2023
Pfizer on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products as governments cut orders and work through inventories.
January 31, 2023
Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment in 2023, intensifying investor concerns over demand for the products as governments cut
January 31, 2023
Prime Minister Han Duck-soo said Seoul could consider lifting the limit on short-term visas for such travellers before the end of February if China's tally of COVID infections proved manageable, the Yonhap news agency said. WHO maintains highest alert over COVID, but sees hope ahead The World Health Organization (WHO) said on Monday that COVID-19 continues to constitute a public health emergency of international concern, its highest form of alert.
January 31, 2023
Pfizer Inc on Tuesday forecasted a bigger than expected drop in sales of its COVID 19 vaccine and treatment for 2023, intensifying investor concerns o...
May 26, 2022
Pfizer Inc will make all of its patented medicines available at a not-for-profit price to 45 of the world's poorest countries
May 25, 2022
(Reuters) - Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday.
May 25, 2022
We’ve had big crises in the past but coming from so many different dimensions this may be quite unique, Standard Chartered Plc Chairman Jose Vinals said.
May 25, 2022
Pfizer Inc (PFE.N) will make all of its patented medicines including Covid-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday.
May 12, 2022
As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment.
May 12, 2022
More than 2.8 million courses of Pfizer Inc’s Covid-19 oral antiviral treatment Paxlovid have been made available at pharmacies around the United States, with the Biden administration working to improve access to the drug. As Paxlovid has become more widely used, some patients have reported that Covid-19 symptoms recurred after completing treatment and experiencing improvement. Here is the latest information...